|LETTER TO EDITOR
|Year : 2018 | Volume
| Issue : 3 | Page : 424-425
A recommendation for cost-effective preparation of phenylephrine
Pradeep Bhatia1, Rakesh Kumar1, Ankur Sharma2, Swati Chhabra1, Sadik Mohammed1
1 Department of Anesthesiology and Critical Care, All India Institute of Medical Sciences, Jodhpur, Rajasthan, India
2 Department of Trauma and Emergency (Anesthesiology), All India Institute of Medical Sciences, Jodhpur, Rajasthan, India
|Date of Web Publication||11-Oct-2018|
Department of Trauma and Emergency (Anesthesiology), All India Institute of Medical Sciences, Jodhpur - 342 008, Rajasthan
Source of Support: None, Conflict of Interest: None
|How to cite this article:|
Bhatia P, Kumar R, Sharma A, Chhabra S, Mohammed S. A recommendation for cost-effective preparation of phenylephrine. J Anaesthesiol Clin Pharmacol 2018;34:424-5
|How to cite this URL:|
Bhatia P, Kumar R, Sharma A, Chhabra S, Mohammed S. A recommendation for cost-effective preparation of phenylephrine. J Anaesthesiol Clin Pharmacol [serial online] 2018 [cited 2019 May 25];34:424-5. Available from: http://www.joacp.org/text.asp?2018/34/3/424/243148
The most common side effect of spinal anesthesia for cesarean section is hypotension due to sympathectomy, which affects approximately 55–90% of patients and if untreated, can compromise feto-placental circulation. Treatment of spinal-induced hypotension includes fluid loading and vasopressors. The vasopressor of choice is phenylephrine, but ephedrine and mephentermine are also being used at some centers.
Mephentermine is available in multidose 10 ml vial (30 mg/ml) and 15 mg/ml ampoule and is administered in the boluses of 3–6 mg to treat hypotension. Ephedrine is available in 30 mg/ml ampoule and used in bolus doses of 5–15 mg. We can obtain these dosages conveniently with dilution in a single syringe.
Phenylephrine is recommended for use in obstetric anesthesia to prevent or treat spinal-induced hypotension. This is due to marked arterial vasoconstriction caused by its α1-agonist action. Though, at times, phenylephrine is used for continuous infusion and thus requires concentrated drug for its use in large quantity. However, routine bolus doses require appropriate dilution.
As per the guidelines issued by various societies, phenylephrine is the recommended vasopressor because of improved fetal acid–base status.,, The recommended bolus dose of phenylephrine for treatment of spinal-induced hypotension is 40–100 mcg. Because it is available as 10 mg/ml ampoule, multiple dilutions are required to get the desired bolus dose of 50–100 mcg/ml. Such an exercise of repeated dilutions is not only inconvenient and time-consuming but may also lead to drug dose errors if not done diligently. Some practitioners prefer to dilute the ampoule drug in 100 ml of normal saline and use it as and when required and serves for both boluses and loading syringes for infusion. This does not require repeated dilution when syringes are used. Although prefilled syringes (PFS) of phenylephrine are available as 50 mcg/ml, its availability and high cost are a concern.
Pharmaceutical companies, many a times, manufacture vials and ampoules of a same drug in different strengths. A desired strength ampoule is adapted to practice depending on the usage requirements. For example, Dalteparin sodium, a low molecular weight heparin is available in both forms, prefilled syringes and multidose vials.
Hence, we recommend that phenylephrine ampoules are also made available in strengths similar to PFS (50, 100 mcg/ml, etc.) or as multidose vials in strengths of 50 or 100 mcg/ml. This will have many advantages like being user-friendly, cost-effective, having ease of drawing up desired dilution of drug, thus saving time in an emergent situation and by avoiding drug wastage when compared to use of a 10 mg/ml ampoule. And to our belief, this will lead to more widespread use of phenylephrine to treat spinal-induced hypotension, especially in obstetric population.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Mercier FJ, Bonnet MP, De la Dorie A, Moufouki M, Banu F, Hanaf A, et al.
Spinal anaesthesia for caesarean section: Fluid loading, vasopressors and hypotension. Ann Fr Anesth Reanim 2007;26:688-93.
Loubert C. Fluid and vasopressor management for cesarean delivery under spinal anesthesia: Continuing professional development. Can J Anaesth 2012;59:604-19.
American Society of Anesthesiologists Task Force on Obstetric Anesthesia. Practice guidelines for obstetric anesthesia: An updated report by the American Society of Anesthesiologists Task Force on Obstetric Anesthesia. Anesthesiology 2007;106:843-63.
Van De Velde M. Belgian guidelines for safe regional anesthesia and obstetric anesthesia and analgesia. Acta Anaesthesiol Belg 2013;64:95-6.
Habib AS. A review of the impact of phenylephrine administration on maternal hemodynamics and maternal and neonatal outcomes in women undergoing cesarean delivery under spinal anesthesia. Anesth Analg 2012;114:377-90.
Kinsella SM, Carvalho B, Dyer RA, Fernando R, McDonnell N, Mercier FJ, et al.
International consensus statement on the management of hypotension with vasopressors during caesarean section under spinal anaesthesia. Anaesthesia 2018;73:71-92.